We conducted a systematic review of literature reporting on the prevalence of assessment measures, treatments, and biomarkers used in the diagnosis and treatment of posttraumatic stress disorder (PTSD) in Iraqi, Kurdish, and Syrian refugees. We performed a search of medical, psychological, and sociological databases on all relevant literature published between January 2011 and March 2016. Seventeen manuscripts met the study inclusion criteria. On the basis of the findings, authors advocate the use of the Harvard Trauma Questionnaire, Hopkins Symptom Checklist-25 (HSCL-25), and Post Migrational Living Difficulties (PMLD) to exclude PTSD noncases and the Clinically Administered PTSD Scale (CAPS) for diagnosis of PTSD in Iraqi, Kurdish, and Syrian refugees in Canada. They further suggest Narrative Exposure Therapy (NET) as the psychological treatment currently with the strongest evidence base in this population. Finally, we advocate continued research into biomarkers as a means of improving and objectifying psychological assessment and treatment of PTSD in Canadian refugee populations.
An important policy initiative implemented for the past 40 years in Canada, refugee private sponsorship has attracted international attention as Europe continues to grapple with